InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-42.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Fonteyne Paul R., Director. Director active across 5 companies, notably Apellis Pharmaceuticals, Inc.. In total, 11 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €165k. History available since 10 August 2021. The latest transaction was disclosed on 1 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Fonteyne Paul R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
30,666 股Common StockSEC:0001193125-26-224618:0
7,961 股0Common StockSEC:0001492422-26-000010:0
6,267 股0Common StockSEC:0001127602-25-000425:0
3,341 股0Common StockSEC:0001127602-24-000120:0
3,867 股0Common StockSEC:0000899243-23-000668:0
13,275 股0Common StockSEC:0001752836-22-000143:0
8,275 股0Common StockSEC:0001752836-22-000098:0
53,832 股Common StockSEC:0001104659-22-057532:0
3,947 股@ US$19.000.0045% mcap50.0% 占其流量Common StockSEC:0000899243-22-001527:0
标准退出：2022年4月6日 (T+90)
4,230 股0Common StockSEC:0001127602-22-000726:0
5,000 股@ US$23.24100.0% 占其流量Common StockSEC:0001752836-21-000236:0
标准退出：2021年11月8日 (T+90)
11 条申报中的 11 条
About Fonteyne Paul R.
Paul R. Fonteyne is a Director of Apellis Pharmaceuticals, Inc. and COVETRUS, INC. He plays a key role in the governance of these companies and in strategic decision-making.
